-
RapaLink-1: Third-Generation mTOR Inhibitor Workflows
2026-08-13
RapaLink-1 combines bivalent mTOR engagement with practical workflows for glioma growth assays, resistance studies, and exploratory dormancy experiments. This guide connects quantified treatment conditions with assay design, formulation control, and troubleshooting for reproducible mTORC1 inhibition.
-
Neuroligin 1, D2-MSNs, and Repetitive Behavior
2026-08-13
This study identifies striatal dopamine D2 receptor-expressing medium spiny neurons (D2-MSNs) as a cell-type-specific circuit node linking Neuroligin 1 deficiency to autistic-like repetitive behaviors. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the authors implicate D2-MSN hyperactivation and PKC overactivity in excessive self-grooming and digging.
-
Torin2 and Mechanistic Cell-Death Assays
2026-08-12
Torin2 is a potent mTOR inhibitor for separating pathway suppression from genuine apoptotic commitment. This article connects Torin2 assay design with the 2025 discovery of Pol II degradation-dependent apoptosis, offering a more rigorous framework for cancer research.
-
CDK4/6–BET Inhibition in Pancreatic Cancer
2026-08-12
Gu et al. show that CDK4/6 inhibition can restrain pancreatic ductal adenocarcinoma growth while unintentionally enhancing invasive and epithelial-to-mesenchymal transition phenotypes. Their study identifies BET inhibition as a mechanistically complementary strategy that restores control of the GSK3β-mediated Wnt/β-catenin axis and produces stronger antitumor effects in vitro and in an orthotopic model.
-
Mubritinib (TAK 165): Reframing OXPHOS in AML
2026-08-11
Mubritinib (TAK 165) illustrates how a compound first associated with HER2 biology can be repositioned through metabolic dependency mapping. This thought-leadership article examines complex I inhibition, OXPHOS-dependent AML, translational assay design, cross-domain opportunities, and practical development strategy.
-
ABT-263 (Navitoclax): Practical Assay Guide
2026-08-11
ABT-263 (Navitoclax, SKU A3007) provides a controlled way to investigate Bcl-2 family-dependent apoptosis in cell and cancer biology workflows. This guide covers stock preparation, controls, assay design, and interpretation; it should not be used for diagnosis, treatment decisions, or clinical dosing.
-
U0126: MEK1/2 Inhibition for Reliable Assays
2026-08-10
U0126 (SKU BA2003) is a cell-permeable, non-ATP-competitive MEK1/2 inhibitor for dissecting MAPK/ERK signaling in viability, proliferation, cytotoxicity, and pathway studies. This scenario-based guide covers dose design, controls, storage, interpretation, and practical supplier-selection criteria for more defensible experiments.
-
SINAT–VAB1 Control of Autophagic Degradation
2026-08-09
A 2026 Arabidopsis study identifies VAB1, a V-ATPase subunit, as a mechanistic link between SINAT-dependent protein turnover, vacuolar acidification, and autophagic vesicle degradation. The findings shift attention from autophagosome formation to the less-defined terminal degradation step and provide a framework for testing how intracellular pH regulation affects plant stress responses.
-
Taltirelin, TRHR, and TH in Striatal Neurons
2026-08-08
Zhu et al. identify a previously underappreciated TRHR–MAPK–RARα–DRD2 signaling axis through which Taltirelin induces tyrosine hydroxylase expression in striatal medium spiny neurons. The work connects Taltirelin’s behavioral effects in a hemi-Parkinson’s disease model with cellular remodeling in the striatum, while also defining important limits for interpreting TH induction as functional dopamine replacement.
-
Trametinib Workflows for MEK–ERK Research
2026-08-07
Trametinib (GSK1120212) supports more than endpoint viability assays: it enables time-resolved MEK–ERK perturbation, genotype-aware oncology studies, and hypothesis testing around APEX2-dependent TERT expression. This practical workflow covers dosing, pathway validation, cell-cycle and apoptosis readouts, and troubleshooting from plate-based assays to exploratory in vivo studies.
-
Purmorphamine as a Smoothened Agonist: Applied Bench Workflo
2026-08-07
Purmorphamine stands out as a precise Smoothened agonist, enabling targeted Hedgehog pathway modulation for bone, neural, and sensory research. This article delivers actionable protocols and troubleshooting insights, with direct translation of novel findings in insect olfaction to mammalian differentiation studies.
-
SCH772984 HCl (SKU B5866): Practical Insights for ERK1/2 Inh
2026-08-06
This article delivers a scenario-based, evidence-driven guide for biomedical researchers using SCH772984 HCl (SKU B5866) as a selective ERK1/2 inhibitor in MAPK pathway studies. It addresses common laboratory challenges—ranging from data reproducibility to product selection—offering actionable, literature-supported recommendations for optimizing cell viability and proliferation assays.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-08-06
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides defined, visible molecular weight standards for SDS-PAGE and Western blotting, aiding precise protein size verification and transfer efficiency monitoring. It is not suitable for protocols requiring chelation or applications outside the 10–250 kDa range.
-
Torin2: Potent mTOR Inhibitor for Cancer Research Workflows
2026-08-05
Torin2 empowers researchers to achieve high-precision mTOR pathway inhibition with outstanding selectivity and reproducibility, especially in apoptosis and cell viability assays. This guide distills optimized protocols, troubleshooting strategies, and the latest mechanistic insights to maximize the value of Torin2 in translational cancer research.
-
AG-126 (Tyrphostin AG-126): Applied ERK Pathway Inhibition i
2026-08-05
AG-126 (Tyrphostin AG-126) empowers researchers to dissect ERK-mediated signaling with precision, as demonstrated in advanced neurobehavioral models of autism spectrum disorder. Its selective inhibition profile and robust in vivo compatibility make it an indispensable tool for translational neuroscience and inflammation studies.